Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Tseng

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2022
Report of the First International Symposium on NUT CarcinomaChristopher A French, Michael L Cheng, Glenn J Hanna, et al.
The American Surgeon|November 11, 2021
Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the ExtremityChelsea R Olson, Lorena P Suarez-Kelly, Cecilia G Ethun, et al.
Journal of Surgical Oncology|August 10, 2021
A novel preoperative risk score to guide patient selection for resection of soft tissue sarcoma lung metastases: An analysis from the United States Sarcoma CollaborativeRachel M Lee, Cecilia G Ethun, Adriana C Gamboa, et al.
Annals of Surgical Oncology|July 12, 2024
Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical TrialKayla M Switalla, Judy C Boughey, Katrina Dimitroff, et al.
Journal of Surgical Oncology|July 13, 2021
A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcomaMalcolm H Squires, Cecilia G Ethun, Erin E Donahue, et al.
Annals of Surgical Oncology|January 11, 2022
Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic NomogramsMalcolm Hart Squires, Cecilia G Ethun, Erin E Donahue, et al.
Annals of Surgical Oncology|August 23, 2025
Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical TrialJulie Van Hassel, Katrina Dimitroff, Christina Yau, et al.
Annals of Surgical Oncology|August 29, 2025
ASO Visual Abstract: Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical TrialJulie Van Hassel, Katrina Dimitroff, Christina Yau, et al.
Cancer Cell|November 18, 2022
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohortsSiri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, et al.
Cancer Cell|July 11, 2023
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohortsSiri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2022
Report of the First International Symposium on NUT CarcinomaChristopher A French, Michael L Cheng, Glenn J Hanna, et al.
The American Surgeon|November 11, 2021
Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the ExtremityChelsea R Olson, Lorena P Suarez-Kelly, Cecilia G Ethun, et al.
Journal of Surgical Oncology|August 10, 2021
A novel preoperative risk score to guide patient selection for resection of soft tissue sarcoma lung metastases: An analysis from the United States Sarcoma CollaborativeRachel M Lee, Cecilia G Ethun, Adriana C Gamboa, et al.
Annals of Surgical Oncology|July 12, 2024
Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical TrialKayla M Switalla, Judy C Boughey, Katrina Dimitroff, et al.
Journal of Surgical Oncology|July 13, 2021
A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcomaMalcolm H Squires, Cecilia G Ethun, Erin E Donahue, et al.
Annals of Surgical Oncology|January 11, 2022
Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic NomogramsMalcolm Hart Squires, Cecilia G Ethun, Erin E Donahue, et al.
Annals of Surgical Oncology|August 23, 2025
Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical TrialJulie Van Hassel, Katrina Dimitroff, Christina Yau, et al.
Annals of Surgical Oncology|August 29, 2025
ASO Visual Abstract: Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical TrialJulie Van Hassel, Katrina Dimitroff, Christina Yau, et al.
Cancer Cell|November 18, 2022
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohortsSiri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, et al.
Cancer Cell|July 11, 2023
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohortsSiri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, et al.
Pageof 10